Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,598 | 1 | 98.4% |
| Food and Beverage | $76.27 | 6 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $4,643 | 5 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $19.42 | 1 | $0 (2024) |
| Biogen, Inc. | $11.81 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.42 | 1 | Novartis Pharmaceuticals Corporation ($19.42) |
| 2018 | $26.57 | 2 | GENZYME CORPORATION ($26.57) |
| 2017 | $4,628 | 4 | GENZYME CORPORATION ($4,616) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Neurology | ||||||
| 08/03/2018 | GENZYME CORPORATION | AUBAGIO (Drug), MS DISEASE STATE | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 05/01/2018 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 07/06/2017 | GENZYME CORPORATION | LEMTRADA (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 06/08/2017 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: NEUROLOGY | ||||||
| 03/21/2017 | GENZYME CORPORATION | LEMTRADA (Drug), MS DISEASE STATE | Food and Beverage | In-kind items and services | $7.60 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 01/23/2017 | GENZYME CORPORATION | AUBAGIO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,598.00 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 103 | 118 | $35,789 | $7,953 |
| 2022 | 5 | 120 | 132 | $42,941 | $8,342 |
| 2021 | 4 | 110 | 139 | $37,454 | $9,071 |
| 2020 | 9 | 245 | 276 | $79,881 | $15,934 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 21 | 21 | $7,060 | $1,986 | 28.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $10,488 | $1,878 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 29 | 31 | $7,290 | $1,719 | 23.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 24 | $7,120 | $1,448 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 23 | $3,831 | $921.01 | 24.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 32 | $17,404 | $3,297 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 29 | 30 | $7,132 | $1,815 | 25.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 30 | $8,710 | $1,640 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 28 | 28 | $4,313 | $1,053 | 24.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 12 | 12 | $5,382 | $536.31 | 10.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 37 | 45 | $10,369 | $3,015 | 29.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 22 | 22 | $11,407 | $2,320 | 20.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 38 | $10,566 | $2,124 | 20.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 30 | 34 | $5,112 | $1,611 | 31.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 37 | 37 | $12,407 | $3,630 | 29.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 37 | 61 | $16,333 | $3,438 | 21.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 22 | 22 | $11,092 | $2,265 | 20.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 42 | 44 | $10,656 | $2,233 | 21.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 45 | 49 | $9,143 | $1,477 | 16.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 13 | 13 | $4,038 | $1,122 | 27.8% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 21 | 21 | $9,177 | $923.63 | 10.1% |
| 95955 | Measurement of electrical activity (eeg) outside the brain during surgery | Facility | 2020 | 12 | 13 | $4,927 | $562.01 | 11.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 16 | 16 | $2,108 | $283.08 | 13.4% |
About Dr. Gary Beaver, DO
Dr. Gary Beaver, DO is a Neurology healthcare provider based in Duluth, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023051356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Beaver, DO has received a total of $4,674 in payments from pharmaceutical and medical device companies, with $19.42 received in 2024. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,598).
As a Medicare-enrolled provider, Beaver has provided services to 578 Medicare beneficiaries, totaling 665 services with total Medicare billing of $41,300. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Duluth, MN
- Active Since 06/14/2006
- Last Updated 10/26/2015
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1023051356
Products in Payments
- AUBAGIO (Drug) $4,625
- KESIMPTA (Drug) $19.42
- LEMTRADA (Drug) $18.47
- TYSABRI (Biological) $11.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Duluth
Dr. Dong Wang, M.d, M.D
Neurology — Payments: $18,017
Dr. Douglas Kaplan, Md, MD
Neurology — Payments: $3,284
Shawnay Mazell, M.d, M.D
Neurology — Payments: $1,885
Dr. Philip Kennedy, Md, MD
Neurology — Payments: $1,053
Rebecca Meyerson
Neurology — Payments: $653.78
Amber Erickson, Md, MD
Neurology — Payments: $247.79